A Belgian single centre outcome study of radioiodine treatment in adolescents with Graves’ disease
A Belgian single centre outcome study of radioiodine treatment in adolescents with Graves’ disease
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Up to 80% of children/adolescents with Graves’ disease (GD) may require second-line treatment with either surgery or radioactive iodine (RAI) therapy after treatment with antithyroid drugs. These interventions aim to induce permanent hypothyroidism, but are not always successful. We aimed to evaluate the initial success rate (within the first year)...
Alternative Titles
Full title
A Belgian single centre outcome study of radioiodine treatment in adolescents with Graves’ disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1a7ec8811a2f490295082bbac3374692
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1a7ec8811a2f490295082bbac3374692
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-82052-z
